References
- Hoppe C, Elger CE. Depression in epilepsy: a critical review from a clinical perspective. Nat Rev Neurol. 2011;7:462-472. https://doi.org/10.1038/nrneurol.2011.104
- Montgomery SA. Antidepressants and seizures: emphasis on newer agents and clinical implications. Int J Clin Pract. 2005;59:1435-1440. https://doi.org/10.1111/j.1368-5031.2005.00731.x
- Cardamone L, Salzberg MR, O'Brien TJ, Jones NC. Antidepressant therapy in epilepsy: can treating the comorbidities affect the underlying disorder? Br J Pharmacol . 2013;168:1531-1554. https://doi.org/10.1111/bph.12052
- Kanner AM. The treatment of depressive disorders in epilepsy: what all neurologists should know. Epilepsia. 2013;54 Suppl 1:3-12.
- Henry JA, Alexander CA, Sener EK. Relative mortality from overdose of antidepressants. BMJ. 1995;310:221-224. https://doi.org/10.1136/bmj.310.6974.221
- Henry JA. Epidemiology and relative toxicity of antidepressant drugs in overdose. Drug Saf. 1997;16:374-390. https://doi.org/10.2165/00002018-199716060-00004
- Reilly JG, Ayis SA, Ferrier IN, Jones SJ, Thomas SH. QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients. Lancet . 2000;355:1048-1052. https://doi.org/10.1016/S0140-6736(00)02035-3
- Scherer D, von Lowenstern K, Zitron E, Scholz EP, Bloehs R, Kathofer S, Thomas D, Bauer A, Katus HA, Karle CA, Kiesecker C. Inhibition of cardiac hERG potassium channels by tetracyclic antidepressant mianserin. Naunyn Schmiedebergs Arch Pharmacol. 2008;378:73-83. https://doi.org/10.1007/s00210-008-0289-4
- Hamid H, Kanner AM. Should antidepressant drugs of the selective serotonin reuptake inhibitor family be tested as antiepileptic drugs? Epilepsy Behav. 2013;26:261-265. https://doi.org/10.1016/j.yebeh.2012.10.009
- Favale E, Audenino D, Cocito L, Albano C. The anticonvulsant effect of citalopram as an indirect evidence of serotonergic impairment in human epileptogenesis. Seizure. 2003;12:316-368. https://doi.org/10.1016/S1059-1311(02)00315-1
- Specchio LM, Iudice A, Specchio N, La Neve A, Spinelli A, Galli R, Rocchi R, Ulivelli M, de Tommaso M, Pizzanelli C, Murri L. Citalopram as treatment of depression in patients with epilepsy. Clin Neuropharmacol. 2004;27:133-136. https://doi.org/10.1097/00002826-200405000-00009
- Favale E, Rubino V, Mainardi P, Lunardi G, Albano C. Anticonvulsant effect of fluoxetine in humans. Neurology. 1995;45:1926-1927. https://doi.org/10.1212/WNL.45.10.1926
- Hyttel J. Citalopram-pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity. Prog Neuropsychopharmacol Biol Psychiatry. 1982;6:277-295. https://doi.org/10.1016/S0278-5846(82)80179-6
- Wong DT, Bymaster FP, Engleman EA. Prozac (fluoxetine, Lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: twenty years since its first publication. Life Sci. 1995;57:411-441. https://doi.org/10.1016/0024-3205(95)00209-O
- Anderson IM. Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability. J Affect Disord. 2000;58:19-36. https://doi.org/10.1016/S0165-0327(99)00092-0
- Montgomery SA. A meta-analysis of the efficacy and tolerability of paroxetine versus tricyclic antidepressants in the treatment of major depression. Int Clin Psychopharmacol. 2001;16:169-178. https://doi.org/10.1097/00004850-200105000-00006
- Curran S. Effect of paroxetine on seizure length during electroconvulsive therapy. Acta Psychiatr Scand. 1995;92:239-240. https://doi.org/10.1111/j.1600-0447.1995.tb09576.x
- Pisani F, Oteri G, Costa C, Di Raimondo G, Di Perri R. Effects of psychotropic drugs on seizure threshold. Drug Saf. 2002;25:91-110. https://doi.org/10.2165/00002018-200225020-00004
- Choi HC, Kim YI, Song HK, Kim JE, Kim DS, Kang TC. Effects of selective serotonin reuptake inhibitors on GABAergic inhibition in the hippocampus of normal and pilocarpine induced epileptic rats. Brain Res . 2010;1357:131-141. https://doi.org/10.1016/j.brainres.2010.08.010
- Boyer WF, Feighner JP. An overview of paroxetine. J Clin Psychiatry. 1992;53 Suppl:3-6.
- Kamal SM. Combination of valproate and paroxetine in mice exposed to picrotoxin. Int J Nanomedicine. 2012;7:2583-2589.
-
Kobayashi T, Washiyama K, Ikeda K. Inhibition of G proteinactivated inwardly rectifying
$K^{+}$ channels by the antidepressant paroxetine. J Pharmacol Sci. 2006;102:278-287. https://doi.org/10.1254/jphs.FP0060708 - Thummler S, Duprat F, Lazdunski M. Antipsychotics inhibit TREK but not TRAAK channels. Biochem Biophys Res Commun. 2007;354:284-289. https://doi.org/10.1016/j.bbrc.2006.12.199
-
Signorini S, Liao YJ, Duncan SA, Jan LY, Stoffel M. Normal cerebellar development but susceptibility to seizures in mice lacking G protein-coupled, inwardly rectifying
$K^{+}$ channel GIRK2. Proc Natl Acad Sci U S A. 1997;94:923-927. https://doi.org/10.1073/pnas.94.3.923 - Franks NP, Honore E. The TREK K2P channels and their role in general anaesthesia and neuroprotection. Trends Pharmacol Sci. 2004;25:601-608. https://doi.org/10.1016/j.tips.2004.09.003
-
Sekirnjak C, Martone ME, Weiser M, Deerinck T, Bueno E, Rudy B, Ellisman M. Subcellular localization of the
$K^{+}$ channel subunit Kv3.1b in selected rat CNS neurons. Brain Res. 1997;766:173-187. https://doi.org/10.1016/S0006-8993(97)00527-1 - Rudy B, Chow A, Lau D, Amarillo Y, Ozaita A, Saganich M, Moreno H, Nadal MS, Hernandez-Pineda R, Hernandez-Cruz A, Erisir A, Leonard C, Vega-Saenz de Miera E. Contributions of Kv3 channels to neuronal excitability. Ann N Y Acad Sci. 1999;868:304-343. https://doi.org/10.1111/j.1749-6632.1999.tb11295.x
- Ozaita A, Martone ME, Ellisman MH, Rudy B. Differential subcellular localization of the two alternatively spliced isoforms of the Kv3.1 potassium channel subunit in brain. J Neurophysiol. 2002;88: 394-408. https://doi.org/10.1152/jn.2002.88.1.394
- Perney TM, Marshall J, Martin KA, Hockfield S, Kaczmarek LK. Expression of the mRNAs for the Kv3.1 potassium channel gene in the adult and developing rat brain. J Neurophysiol. 1992;68:756-766. https://doi.org/10.1152/jn.1992.68.3.756
- Wang LY, Gan L, Forsythe ID, Kaczmarek LK. Contribution of the Kv3.1 potassium channel to high-frequency firing in mouse auditory neurones. J Physiol. 1998;509:183-194. https://doi.org/10.1111/j.1469-7793.1998.183bo.x
-
Erisir A, Lau D, Rudy B, Leonard CS. Function of specific
$K^{+}$ channels in sustained high-frequency firing of fast-spiking neocortical interneurons. J Neurophysiol. 1999;82:2476-2489. https://doi.org/10.1152/jn.1999.82.5.2476 - Kanemasa T, Gan L, Perney TM, Wang LY, Kaczmarek LK. Electrophysiological and pharmacological characterization of a mammalian Shaw channel expressed in NIH 3T3 fibroblasts. J Neurophysiol. 1995;74:207-217. https://doi.org/10.1152/jn.1995.74.1.207
- Sung MJ, Ahn HS, Hahn SJ, Choi BH. Open channel block of Kv3.1 currents by fluoxetine. J Pharmacol Sci. 2008;106:38-45. https://doi.org/10.1254/jphs.FP0070759
- Hahn SJ, Wang LY, Kaczmarek LK. Inhibition by nystatin of Kv1.3 channels expressed in Chinese hamster ovary cells. Neuropharmacology. 1996;35:895-901. https://doi.org/10.1016/0028-3908(96)00094-9
-
Luneau CJ, Williams JB, Marshall J, Levitan ES, Oliva C, Smith JS, Antanavage J, Folander K, Stein RB, Swanson R, et al. Alternative splicing contributes to
$K^{+}$ channel diversity in the mammalian central nervous system. Proc Natl Acad Sci U S A. 1991;88:3932-3936. https://doi.org/10.1073/pnas.88.9.3932 - Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch. 1981;391:85-100. https://doi.org/10.1007/BF00656997
- Snyders DJ, Yeola SW. Determinants of antiarrhythmic drug action. Electrostatic and hydrophobic components of block of the human cardiac hKv1.5 channel. Circ Res. 1995;77:575-583. https://doi.org/10.1161/01.RES.77.3.575
- Woodhull AM. Ionic blockage of sodium channels in nerve. J Gen Physiol. 1973;61:687-708. https://doi.org/10.1085/jgp.61.6.687
- Philipson LH, Malayev A, Kuznetsov A, Chang C, Nelson DJ. Functional and biochemical characterization of the human potassium channel Kv1.5 with a transplanted carboxyl-terminal epitope in stable mammalian cell lines. Biochim Biophys Acta. 1993;1153:111-121. https://doi.org/10.1016/0005-2736(93)90282-5
- Snyders DJ, Tamkun MM, Bennett PB. A rapidly activating and slowly inactivating potassium channel cloned from human heart. Functional analysis after stable mammalian cell culture expression. J Gen Physiol . 1993;101:513-543. https://doi.org/10.1085/jgp.101.4.513
- Choi BH, Choi JS, Jeong SW, Hahn SJ, Yoon SH, Jo YH, Kim MS. Direct block by bisindolylmaleimide of rat Kv1.5 expressed in Chinese hamster ovary cells. J Pharmacol Exp Ther. 2000;293:634-640.
- Valenzuela C, Delpon E, Franqueza L, Gay P, Perez O, Tamargo J, Snyders DJ. Class III antiarrhythmic effects of zatebradine. Time-, state-, use-, and voltage-dependent block of hKv1.5 channels. Circulation. 1996;94:562-570. https://doi.org/10.1161/01.CIR.94.3.562
- Delpon E, Valenzuela C, Gay P, Franqueza L, Snyders DJ, Tamargo J. Block of human cardiac Kv1.5 channels by loratadine: voltage-, time- and use-dependent block at concentrations above therapeutic levels. Cardiovasc Res. 1997;35:341-350. https://doi.org/10.1016/S0008-6363(97)00121-1
- Franqueza L, Valenzuela C, Delpon E, Longobardo M, Caballero R, Tamargo J. Effects of propafenone and 5-hydroxy-propafenone on hKv1.5 channels. Br J Pharmacol. 1998;125:969-978. https://doi.org/10.1038/sj.bjp.0702129
- Sung MJ, Hahn SJ, Choi BH. Effect of psoralen on the cloned Kv3.1 currents. Arch Pharm Res. 2009;32:407-412. https://doi.org/10.1007/s12272-009-1314-y
- Choi BH, Choi JS, Yoon SH, Rhie DJ, Min DS, Jo YH, Kim MS, Hahn SJ. Effects of norfluoxetine, the major metabolite of fluoxetine, on the cloned neuronal potassium channel Kv3.1. Neuropharmacology. 2001;41:443-453. https://doi.org/10.1016/S0028-3908(01)00088-0
- Choi JS, Hahn SJ, Rhie DJ, Yoon SH, Jo YH, Kim MS. Mechanism of fluoxetine block of cloned voltage-activated potassium channel Kv1.3. J Pharmacol Exp Ther. 1999;291:1-6.
- Vasskog T, Berger U, Samuelsen PJ, Kallenborn R, Jensen E. Selective serotonin reuptake inhibitors in sewage influents and effluents from Tromso, Norway. J Chromatogr A. 2006;1115:187-195. https://doi.org/10.1016/j.chroma.2006.02.091
- Tytgat J1, Maertens C, Daenens P. Effect of fluoxetine on a neuronal, voltage-dependent potassium channel (Kv1.1). Br J Pharmacol. 1997;122:1417-1424. https://doi.org/10.1038/sj.bjp.0701545
- Snyders J, Knoth KM, Roberds SL, Tamkun MM. Time-, voltage-, and state-dependent block by quinidine of a cloned human cardiac potassium channel. Mol Pharmacol. 1992;41:322-330.
- Lee HM, Hahn SJ, Choi BH. Open channel block of Kv1.5 currents by citalopram. Acta Pharmacol Sin. 2010;31:429-435. https://doi.org/10.1038/aps.2010.14
-
Grissmer S, Ghanshani S, Dethlefs B, McPherson JD, Wasmuth JJ, Gutman GA, Cahalan MD, Chandy KG. The Shaw-related potassium channel gene, Kv3.1, on human chromosome 11, encodes the type l
$K^{+}$ channel in T cells. J Biol Chem. 1992;267:20971-20979. -
Hernandez-Pineda R, Chow A, Amarillo Y, Moreno H, Saganich M, Vega-Saenz de Miera EC, Hernandez-Cruz A, Rudy B. Kv3.1- Kv3.2 channels underlie a high-voltage-activating component of the delayed rectifier
$K^{+}$ current in projecting neurons from the globus pallidus. J Neurophysiol. 1999;82:1512-1528. https://doi.org/10.1152/jn.1999.82.3.1512 - Bezaire MJ, Soltesz I. Quantitative assessment of CA1 local circuits: knowledge base for interneuron-pyramidal cell connectivity. Hippocampus. 2013;23:751-785. https://doi.org/10.1002/hipo.22141
-
Wang GK, Mitchell J, Wang SY. Block of persistent late
$Na^{+}$ cur rents by antidepressant sertraline and paroxetine. J Membr Biol. 2008;222:79-90. https://doi.org/10.1007/s00232-008-9103-y - Dick IE, Brochu RM, Purohit Y, Kaczorowski GJ, Martin WJ, Priest BT. Sodium channel blockade may contribute to the analgesic efficacy of antidepressants. J Pain. 2007;8:315-324. https://doi.org/10.1016/j.jpain.2006.10.001
- Huang CJ, Harootunian A, Maher MP, Quan C, Raj CD, McCormack K, Numann R, Negulescu PA, Gonzalez JE. Characterization of voltage-gated sodium-channel blockers by electrical stimulation and fluorescence detection of membrane potential. Nat Biotechnol. 2006;24:439-446. https://doi.org/10.1038/nbt1194
- Black JA, Waxman SG. Noncanonical roles of voltage-gated sodium channels. Neuron. 2013;80:280-291. https://doi.org/10.1016/j.neuron.2013.09.012
Cited by
- The effect of duloxetine on penicillin-induced epileptiform activity in rats vol.41, pp.4, 2018, https://doi.org/10.1080/01616412.2018.1560642
- Cross Pharmacological, Biochemical and Computational Studies of a Human Kv3.1b Inhibitor from Androctonus australis Venom vol.22, pp.22, 2018, https://doi.org/10.3390/ijms222212290
- Inhibitory effect of the selective serotonin reuptake inhibitor paroxetine on human Kv1.3 channels vol.912, pp.None, 2021, https://doi.org/10.1016/j.ejphar.2021.174567